Fig 1: DNA binding accelerates KLK7 inhibition by vaspin. (A) Analysis of DNA‐accelerated complex formation of vaspin and KLK7 in the presence of increasing concentrations of 40 base ssDNA, including a control without DNA, after 2‐, 5‐, and 10‐min reaction times. Coomassie Blue‐stained SDS gel of vaspin and KLK7 incubated at a fixed molar ratio (1 : 1) and with increasing concentrations of DNA (1–50‐fold vaspin). Increasing band intensities of complexed and N‐terminally cleaved (after 2 min) and decreasing band intensity of RCL‐cleaved vaspin (after 10 min) are indicated by asterisks and confirm the accelerated interaction of serpin and protease in the presence of DNA. From top to bottom the labels describe: Vaspin‐KLK7 complex, native vaspin, N‐terminally cleaved vaspin, N + C‐terminally cleaved vaspin, and KLK7. (B) Analysis of DNA‐accelerated complex formation of vaspin and KLK7 in the presence of increasing concentrations of 20, 40 (as in A), 60, and 120 base ssDNA as well as 5.4‐kb linear dsDNA and a control without DNA after 2‐, 5‐ and 10‐min reaction times. Only the vaspin‐KLK7 complex band is shown. (C) Analysis of KLK7 proteolytic activity in the presence of increasing concentrations of 5.4‐kb linear dsDNA using a fluorogenic peptide substrate. (D) Continuous monitoring of the vaspin‐KLK7 inhibition reaction in the presence of increasing concentrations of linear dsDNA measuring residual activity using a fluorogenic substrate peptide. Arrowheads indicate concentration‐dependent reduction of KLK7 activity in the presence of DNA. (E) DNA‐induced acceleration of vaspin inhibition of KLK7 in the presence of DNA, corrected for KLK7 activity in the presence of corresponding DNA concentration. The bell‐shaped curve suggests the bridging or template effect as the major contribution to DNA‐accelerated vaspin reactivity. Gels are representative of at least n = 2 independent experiments, data in (D), (E) are represented as mean + SEM of n = 5 technical replicates. R.F.U., relative fluorescence units.
Fig 2: Nonheparin‐binding (NHB) vaspin mutant still binds DNA. (A) DNA‐affinity chromatography analysis of wild‐type (WT) and NHB vaspin using dsDNA‐cellulose and NaCl‐gradient elution. (B) DRaCALA‐based determination of NHB vaspin (1 μm) binding to radiolabeled 60 base ssDNA (50 nm) in Buffer 2 (20 mm Tris/HCl, pH 7.8, 15 mm NaCl). (C) K D was determined by nonlinear regression (one site—specific binding) plotting % binding versus protein concentration and is indicated by solid lines. Data in (B, C) are presented as mean + SEM of n = 3 technical replicates. (D) Analysis of DNA‐accelerated complex formation of WT or NHB vaspin and KLK7 in the presence of increasing concentrations of 5.4‐kb linear dsDNA and a control without DNA after 2‐min reaction time by SDS/PAGE. Arrowheads indicate bands from top to bottom corresponding to: (1) Vaspin‐KLK7 complex, (2) native vaspin, (3) N‐terminally cleaved vaspin, (4) N + C‐terminally cleaved vaspin, (5) KLK7. (E) Crystal structure of cleaved vaspin (pdb id: 5EI0) with the inserted reactive center loop (RCL) highlighted in red. (F) Electrostatic potential at the molecular surface [color coded from −5 kT/e (red) to +5 kT/e (blue)] on the backside of WT vaspin (pdb id: 4IF8) reveals a basic patch. (G) Crystal structure of native vaspin (pdb id: 4IF8) with helix A and G highlighted in yellow and lysine residues (K61/K62/K281/K285; mutated in the hAhG‐4KA vaspin variant) shown as sticks. Figures E–G were generated using pymol. (H) DNA‐affinity chromatography of WT, cleaved, and hAhG‐4KA vaspin using dsDNA cellulose and NaCl‐gradient elution. Data (A, D, and H) are representative of two independent experiments.
Fig 3: Crystal structure of polyphosphate polyP45‐bound vaspin. (A) Analysis of DNA‐accelerated complex formation of vaspin [wild‐type (WT) and nonheparin‐binding (NHB)] and KLK7 (1 : 1 molar ratio) in the presence of increasing concentrations of polyP45 (0 to 20‐fold vaspin) and a control without DNA after 2‐min reaction time by SDS/PAGE. WT vaspin shows accelerated complex formation and this is lost for the NHB variant. Arrowheads indicate bands from top to bottom corresponding to (1) Vaspin‐KLK7 complex, (2) native vaspin, (3) N‐terminally cleaved vaspin, (4) N + C‐terminally cleaved vaspin, (5) KLK7. (B) Crystal structure of polyP45‐bound WT vaspin (pdb id: 9IH0). Twelve phosphate residues were modeled into the 2F o − F c density (yellow). The polyphosphate binds between the two protein chains in the asymmetric unit. The view is along the noncrystallographic twofold symmetry axis. (C) Overview of the binding site of polyP45 to vaspin. The reactive center loop is shown in red. (D) Close‐up view of the residues interacting with the polyphosphate chain. (E) Electrostatic potential mapped to the molecular surface [color coded from −5 kT/e (red) to +5 kT/e (blue)]. The polyphosphate chain is located at the basic patch at the central beta‐sheet A of vaspin. Figures B–E were generated using pymol.
Supplier Page from BioLegend for Recombinant Human KLK7 (carrier-free)